Mechanical activation of angiotensin II type 1 receptors causes actin remodelling and myogenic responsiveness in skeletal muscle arterioles

Journal of Physiology

Volumn 594, Issue 23, 2016, Pages 7027-7047

  Hong, Kwangseok ^a,b,e   Zhao, Guiling ^c   Hong, Zhongkui ^a,d   Sun, Zhe ^a,b   Yang, Yan ^a   Clifford, Philip S ^c   Davis, Michael J ^a,b   Meininger, Gerald A ^a,b   Hill, Michael A ^a,b  

^a UNIVERSITY OF MISSOURI   (United States)

^b University of Missouri   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^d University of South Dakota   (United States)

^e UNIVERSITY OF VIRGINIA   (United States)

Author keywords

actin stress fibres; cytoskeleton; mechanotransduction; myogenic response; protein kinase C; type 1 angiotensin II receptor; vascular smooth muscle cell signalling

Indexed keywords

1 OLEOYL 2 ACETYL SN GLYCEROL; 2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; ACTIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN II; CALCIUM ION; CANDESARTAN; DIACYLGLYCEROL DERIVATIVE; G ACTIN; G PROTEIN COUPLED RECEPTOR; PROTEIN KINASE C; UNCLASSIFIED DRUG; 1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; 1-OLEOYL-2-ACETYLGLYCEROL; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BENZIMIDAZOLE DERIVATIVE; BISINDOLYLMALEIMIDE I; CAPTOPRIL; DIACYLGLYCEROL; IMIDAZOLE DERIVATIVE; INDOLE DERIVATIVE; LOSARTAN; LOSARTAN CARBOXYLIC ACID; MALEIMIDE DERIVATIVE; OLMESARTAN; PYRIDINE DERIVATIVE; TETRAZOLE DERIVATIVE; VASOCONSTRICTOR AGENT;

ACTIN FILAMENT; ACTIN POLYMERIZATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTERIOLE; ARTERY DIAMETER; ARTICLE; ATOMIC FORCE MICROSCOPY; CALCIUM CELL LEVEL; CALCIUM SIGNALING; CELL SWELLING; CONTROLLED STUDY; CREMASTER MUSCLE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; HORMONE SYNTHESIS; MALE; MUSCLE FUNCTION; MYOGRAPHY; NONHUMAN; PRIORITY JOURNAL; PROTEIN MODIFICATION; PROTEIN PROTEIN INTERACTION; RAT; SKELETAL MUSCLE; VASCULAR SMOOTH MUSCLE CELL; VASOCONSTRICTION; ABDOMINAL WALL MUSCULATURE; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL CULTURE; DRUG EFFECTS; GENETICS; MUSCLE DEVELOPMENT; PHYSIOLOGY; PRESSURE; SKELETAL MUSCLE CELL; SPRAGUE DAWLEY RAT;

ABDOMINAL MUSCLES; ACTINS; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; ANTIHYPERTENSIVE AGENTS; ARTERIOLES; BENZIMIDAZOLES; CAPTOPRIL; CELLS, CULTURED; DIGLYCERIDES; IMIDAZOLES; INDOLES; LOSARTAN; MALE; MALEIMIDES; MUSCLE DEVELOPMENT; MUSCLE FIBERS, SKELETAL; PRESSURE; PROTEIN KINASE C; PYRIDINES; RATS, SPRAGUE-DAWLEY; RECEPTOR, ANGIOTENSIN, TYPE 1; TETRAZOLES; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS;

EID: 84992398826     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/JP272834     Document Type: Article

References (86)

1. Abd-Elrahman KS, Walsh MP & Cole WC (2015). Abnormal Rho-associated kinase activity contributes to the dysfunctional myogenic response of cerebral arteries in type 2 diabetes. Can J Physiol Pharmacol 93, 177–184.
2. Akazawa H, Yasuda N & Komuro I (2009). Mechanisms and functions of agonist-independent activation in the angiotensin II type 1 receptor. Mol Cell Endocrinol 302, 140–147.
3. Blodow S, Schneider H, Storch U, Wizemann R, Forst AL, Gudermann T & Schnitzler M (2014). Novel role of mechanosensitive AT1B receptors in myogenic vasoconstriction. Pflugers Arch 466, 1343–1353.
4. Brayden JE, Li Y & Tavares MJ (2013). Purinergic receptors regulate myogenic tone in cerebral parenchymal arterioles. J Cereb Blood Flow Metab 33, 293–299.
5. Bulley S, Neeb ZP, Burris SK, Bannister JP, Thomas-Gatewood CM, Jangsangthong W & Jaggar JH (2012). TMEM16A/ANO1 channels contribute to the myogenic response in cerebral arteries. Circ Res 111, 1027–1036.
6. Cipolla MJ, Gokina NI & Osol G (2002). Pressure-induced actin polymerization in vascular smooth muscle as a mechanism underlying myogenic behavior. FASEB J 16, 72–76.
7. Cipolla MJ & Osol G (1998). Vascular smooth muscle actin cytoskeleton in cerebral artery forced dilatation. Stroke 29, 1223–1228.
8. Cole WC & Welsh DG (2011). Role of myosin light chain kinase and myosin light chain phosphatase in the resistance arterial myogenic response to intravascular pressure. Arch Biochem Biophys 510, 160–173.
9. Colinas O, Moreno-Dominguez A, Zhu HL, Walsh EJ, Perez-Garcia MT, Walsh MP, Cole WC (2015). α5-Integrin-mediated cellular signaling contributes to the myogenic response of cerebral resistance arteries. Biochem Pharmacol 97, 281–291.
10. Davis MJ, Donovitz JA & Hood JD (1992). Stretch-activated single-channel and whole cell currents in vascular smooth muscle cells. Am J Physiol Cell Physiol 262, C1083–C1088.
11. Davis MJ & Hill MA (1999). Signaling mechanisms underlying the vascular myogenic response. Physiol Rev 79, 387–423.
12. Earley S, Straub SV & Brayden JE (2007). Protein kinase C regulates vascular myogenic tone through activation of TRPM4. Am J Physiol Heart Circ Physiol 292, H2613–H2622.
13. Earley S, Waldron BJ & Brayden JE (2004). Critical role for transient receptor potential channel TRPM4 in myogenic constriction of cerebral arteries. Circ Res 95, 922–929.
14. El-Yazbi AF, Abd-Elrahman KS & Moreno-Dominguez A (2015). PKC-mediated cerebral vasoconstriction: Role of myosin light chain phosphorylation versus actin cytoskeleton reorganization. Biochem Pharmacol 95, 263–278.
15. Eto M (2009). Regulation of cellular protein phosphatase-1 (PP1) by phosphorylation of the CPI-17 family, C-kinase-activated PP1 inhibitors. J Biol Chem 284, 35273–35277.
16. Flavahan NA, Bailey SR, Flavahan WA, Mitra S & Flavahan S (2005). Imaging remodeling of the actin cytoskeleton in vascular smooth muscle cells after mechanosensitive arteriolar constriction. Am J Physiol Heart Circ Physiol 288, H660–H669.
17. Foote CA, Castorena-Gonzalez JA, Staiculescu MC, Clifford PS, Hill MA, Meininger GA & Martinez-Lemus LA (2016). Brief serotonin exposure initiates arteriolar inward remodeling processes in vivo that involve transglutaminase activation and actin cytoskeleton reorganization. Am J Physiol Heart Circ Physiol 310, H188–H198.
18. Gonzales AL, Yang Y, Sullivan MN, Sanders L, Dabertrand F, Hill-Eubanks DC, Nelson MT & Earley S (2014). A PLCgamma1-dependent, force-sensitive signaling network in the myogenic constriction of cerebral arteries. Sci Signal 7, ra49.
19. Gruden G, Thomas S, Burt D, Zhou W, Chusney G, Gnudi L & Viberti G (1999). Interaction of angiotensin II and mechanical stretch on vascular endothelial growth factor production by human mesangial cells. J Am Soc Nephrol 10, 730–737.
20. Gschwend S, Henning RH, Pinto YM, de ZD, van Gilst WH & Buikema H (2003). Myogenic constriction is increased in mesenteric resistance arteries from rats with chronic heart failure: instantaneous counteraction by acute AT1 receptor blockade. Br J Pharmacol 139, 1317–1325.
21. Hill MA, Falcone JC & Meininger GA (1990). Evidence for protein kinase C involvement in arteriolar myogenic reactivity. Am J Physiol Heart Circ Physiol 259, H1586–H1594.
22. Hill MA & Meininger GA (1994). Calcium entry and myogenic phenomena in skeletal muscle arterioles. Am J Physiol Heart Circ Physiol 267, H1085–H1092.
23. Hill MA & Meininger GA (2012). Arteriolar vascular smooth muscle cells: mechanotransducers in a complex environment. Int J Biochem Cell Biol 44, 1505–1510.
24. Hill MA, Meininger GA, Davis MJ & Laher I (2009). Therapeutic potential of pharmacologically targeting arteriolar myogenic tone. Trends Pharmacol Sci 30, 363–374.
25. Hill MA, Potocnik SJ, Martinez-Lemus LA & Meininger GA (2003). Delayed arteriolar relaxation after prolonged agonist exposure: functional remodeling involving tyrosine phosphorylation. Am J Physiol Heart Circ Physiol 285, H849–H856.
26. + channels (BKCa) and arteriolar myogenic signaling. FEBS Lett 584, 2033–2042.
27. i are not obligatory for myogenic constriction. Am J Physiol Heart Circ Physiol 278, H345–H352.
28. 2+ signaling pathways underlying myogenic reactivity. J Appl Physiol (1985) 91, 973–983.
29. Hong Z, Sun Z, Li M, Li Z, Bunyak F, Ersoy I, Trzeciakowski JP, Staiculescu MC, Jin M, Martinez-Lemus L, Hill MA, Palaniappan K & Meininger GA (2014). Vasoactive agonists exert dynamic and coordinated effects on vascular smooth muscle cell elasticity, cytoskeletal remodelling and adhesion. J Physiol 592, 1249–1266.
30. Horiuchi M & Mogi M (2011). Role of angiotensin II receptor subtype activation in cognitive function and ischaemic brain damage. Br J Pharmacol 163, 1122–1130.
31. Hughes JM & Bund SJ (2002). Arterial myogenic properties of the spontaneously hypertensive rat. Exp Physiol 87, 527–534.
32. Jackson TY, Sun Z, Martinez-Lemus LA, Hill MA & Meininger GA (2010). N-cadherin and integrin blockade inhibit arteriolar myogenic reactivity but not pressure-induced increases in intracellular Ca. Front Physiol 1, 165.
33. 2 to regulate activation of TRPC6/C7 channels by diacylglycerol in native vascular myocytes. J Physiol 588, 1419–1433.
34. Karlon WJ, Hsu PP, Li S, Chien S, McCulloch AD & Omens JH (1999). Measurement of orientation and distribution of cellular alignment and cytoskeletal organization. Ann Biomed Eng 27, 712–720.
35. Kauffenstein G, Laher I, Matrougui K, Guerineau NC & Henrion D (2012). Emerging role of G protein-coupled receptors in microvascular myogenic tone. Cardiovasc Res 95, 223–232.
36. Kim EC, Choi SK, Lim M, Yeon SI & Lee YH (2013). Role of endogenous ENaC and TRP channels in the myogenic response of rat posterior cerebral arteries. PLoS One 8, e84194.
37. 2+] in cerebral arteries of rat by membrane potential and intravascular pressure. J Physiol 508, 199–209.
38. 2+ signaling. Am J Physiol Heart Circ Physiol 289, H1326–H1334.
39. Large WA, Saleh SN & Albert AP (2009). Role of phosphoinositol 4,5-bisphosphate and diacylglycerol in regulating native TRPC channel proteins in vascular smooth muscle. Cell Calcium 45, 574–582.
40. Lee S, Yang Y, Tanner MA, Li M & Hill MA (2015). Heterogeneity in Kv7 channel function in the cerebral and coronary circulation. Microcirculation 22, 109–121.
41. Li Y, Baylie RL, Tavares MJ & Brayden JE (2014). TRPM4 channels couple purinergic receptor mechanoactivation and myogenic tone development in cerebral parenchymal arterioles. J Cereb Blood Flow Metab 34, 1706–1714.
42. Lidington D, Schubert R & Bolz SS (2013). Capitalizing on diversity: an integrative approach towards the multiplicity of cellular mechanisms underlying myogenic responsiveness. Cardiovasc Res 97, 404–412.
43. Livak KJ & Schmittgen TD (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25, 402–408.
44. Luykenaar KD, El-Rahman RA, Walsh MP & Welsh DG (2009). Rho-kinase-mediated suppression of KDR current in cerebral arteries requires an intact actin cytoskeleton. Am J Physiol Heart Circ Physiol 296, H917–H926.
45. 2+ waves in smooth muscle as revealed by localized photolysis of caged inositol 1,4,5-trisphosphate. J Biol Chem 279, 8417–8427.
46. Maron BA & Leopold JA (2014). The role of the renin—angiotensin–aldosterone system in the pathobiology of pulmonary arterial hypertension (2013 Grover Conference series). Pulm Circ 4, 200–210.
47. Martinez-Lemus LA, Wu X, Wilson E, Hill MA, Davis GE, Davis MJ & Meininger GA (2003). Integrins as unique receptors for vascular control. J Vasc Res 40, 211–233.
48. Martinez-Lemus LA, Zhao G, Galinanes EL & Boone M (2011). Inward remodeling of resistance arteries requires reactive oxygen species-dependent activation of matrix metalloproteinases. Am J Physiol Heart Circ Physiol 300, H2005–H2015.
49. Mathar I, Vennekens R, Meissner M, Kees F, Van der Mieren G, Camacho Londono JE, Uhl S, Voets T, Hummel B, van den Bergh A, Herijgers P, Nilius B, Flockerzi V, Schweda F & Freichel M (2010). Increased catecholamine secretion contributes to hypertension in TRPM4-deficient mice. J Clin Invest 120, 3267–3279.
50. Mederos y Schnitzler M, Storch U & Gudermann T (2011). AT1 receptors as mechanosensors. Curr Opin Pharmacol 11, 112–116.
51. Mederos y Schnitzler M, Storch U, Meibers S, Nurwakagari P, Breit A, Essin K, Gollasch M & Gudermann T (2008). Gq-coupled receptors as mechanosensors mediating myogenic vasoconstriction. EMBO J 27, 3092–3103.
52. Milligan G (2003). Constitutive activity and inverse agonists of G protein-coupled receptors: a current perspective. Mol Pharmacol 64, 1271–1276.
53. 2+ sensitization due to myosin light chain phosphatase inhibition and cytoskeletal reorganization in the myogenic response of skeletal muscle resistance arteries. J Physiol 591, 1235–1250.
54. Moreno-Dominguez A, El-Yazbi AF, Zhu HL, Colinas O, Zhong XZ, Walsh EJ, Cole DM, Kargacin GJ, Walsh MP & Cole WC (2014). Cytoskeletal reorganization evoked by Rho-associated kinase- and protein kinase C-catalyzed phosphorylation of cofilin and heat shock protein 27, respectively, contributes to myogenic constriction of rat cerebral arteries. J Biol Chem 289, 20939–20952.
55. Mueller KB, Bender SB, Hong K, Yang Y, Aronovitz M, Jaisser F, Hill MA & Jaffe IZ (2015). Endothelial mineralocorticoid receptors differentially contribute to coronary and mesenteric vascular function without modulating blood pressure. Hypertension 66, 988–997.
56. Muranyi A, Derkach D, Erdodi F, Kiss A, Ito M & Hartshorne DJ (2005). Phosphorylation of Thr695 and Thr850 on the myosin phosphatase target subunit: inhibitory effects and occurrence in A7r5 cells. FEBS Lett 579, 6611–6615.
57. Narayanan J, Imig M, Roman RJ & Harder DR (1994). Pressurization of isolated renal arteries increases inositol trisphosphate and diacylglycerol. Am J Physiol Heart Circ Physiol 266, H1840–H1845.
58. Nguyen Dinh CA & Touyz RM (2011). A new look at the renin–angiotensin system – focusing on the vascular system. Peptides 32, 2141–2150.
59. + channel (BKCa) α-subunit splice variants in resistance arteries from rat cerebral and skeletal muscle vasculature. PLoS One 9, e98863.
60. Osol G, Laher I & Cipolla M (1991). Protein kinase C modulates basal myogenic tone in resistance arteries from the cerebral circulation. Circ Res 68, 359–367.
61. Osol G, Laher I & Kelley M (1993). Myogenic tone is coupled to phospholipase C and G protein activation in small cerebral arteries. Am J Physiol Heart Circ Physiol 265, H415–H420.
62. Parker TG, Packer SE & Schneider MD (1990). Peptide growth factors can provoke “fetal” contractile protein gene expression in rat cardiac myocytes. J Clin Invest 85, 507–514.
63. Sadoshima J, Xu Y, Slayter HS & Izumo S (1993). Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro. Cell 75, 977–984.
64. Schleifenbaum J, Kassmann M, Szijarto IA, Hercule HC, Tano JY, Weinert S, Heidenreich M, Pathan AR, Anistan YM, Alenina N, Rusch NJ, Bader M, Jentsch TJ & Gollasch M (2014). Stretch-activation of angiotensin II type 1a receptors contributes to the myogenic response of mouse mesenteric and renal arteries. Circ Res 115, 263–272.
65. 2+ sensitivity regulation in promoting myogenic vasoconstriction. Cardiovasc Res 77, 8–18.
66. Schwartz MA (2010). Integrins and extracellular matrix in mechanotransduction. Cold Spring Harb Perspect Biol 2, a005066.
67. Slish DF, Welsh DG & Brayden JE (2002). Diacylglycerol and protein kinase C activate cation channels involved in myogenic tone. Am J Physiol Heart Circ Physiol 283, H2196–H2201.
68. Spassova MA, Hewavitharana T, Xu W, Soboloff J & Gill DL (2006). A common mechanism underlies stretch activation and receptor activation of TRPC6 channels. Proc Natl Acad Sci USA 103, 16586–16591.
69. Storch U, Blodow S, Gudermann T & Mederos y Schnitzler M (2015). Cysteinyl leukotriene 1 receptors as novel mechanosensors mediating myogenic tone together with angiotensin II type 1 receptors-brief report. Arterioscler Thromb Vasc Biol 35, 121–126.
70. Storch U, Mederos y Schnitzler M & Gudermann T (2012). G protein-mediated stretch reception. Am J Physiol Heart Circ Physiol 302, H1241–H1249.
71. Sun Z, Li Z & Meininger GA (2012). Mechanotransduction through fibronectin-integrin focal adhesion in microvascular smooth muscle cells: is calcium essential? Am J Physiol Heart Circ Physiol 302, H1965–H1973.
72. Sun Z, Martinez-Lemus LA, Hill MA & Meininger GA (2008). Extracellular matrix-specific focal adhesions in vascular smooth muscle produce mechanically active adhesion sites. Am J Physiol Cell Physiol 295, C268–C278.
73. Tan CO, Hamner JW & Taylor JA (2013). The role of myogenic mechanisms in human cerebrovascular regulation. J Physiol 591, 5095–5105.
74. Tian Y, Baukal AJ, Sandberg K, Bernstein KE, Balla T & Catt KJ (1996). Properties of AT1a and AT1b angiotensin receptors expressed in adrenocortical Y-1 cells. Am J Physiol Endocrinol Metab 270, E831–E839.
75. Turner SR & Macdonald JA (2014). Novel contributions of the smoothelin-like 1 protein in vascular smooth muscle contraction and its potential involvement in myogenic tone. Microcirculation 21, 249–258.
76. Walsh MP & Cole WC (2013). The role of actin filament dynamics in the myogenic response of cerebral resistance arteries. J Cereb Blood Flow Metab 33, 1–12.
77. Walsh MP, Thornbury K, Cole WC, Sergeant G, Hollywood M, McHale N (2011). Rho-associated kinase plays a role in rabbit urethral smooth muscle contraction, but not via enhanced myosin light chain phosphorylation. Am J Physiol Renal Physiol 300, F73–F85.
78. Welsh DG, Morielli AD, Nelson MT & Brayden JE (2002). Transient receptor potential channels regulate myogenic tone of resistance arteries. Circ Res 90, 248–250.
79. Welsh DG, Nelson MT, Eckman DM & Brayden JE (2000). Swelling-activated cation channels mediate depolarization of rat cerebrovascular smooth muscle by hyposmolarity and intravascular pressure. J Physiol 527, 139–148.
80. Wynne BM, Chiao CW & Webb RC (2009). Vascular smooth muscle cell signaling mechanisms for contraction to angiotensin II and endothelin-1. J Am Soc Hypertens 3, 84–95.
81. Yang Y, Murphy TV, Ella SR, Grayson TH, Haddock R, Hwang YT, Braun AP, Peichun G, Korthuis RJ, Davis MJ & Hill MA (2009). Heterogeneity in function of small artery smooth muscle BKCa: involvement of the beta1-subunit. J Physiol 587, 3025–3044.
82. Zhao Y, Flavahan S, Leung SW, Xu A, Vanhoutte PM & Flavahan NA (2015). Elevated pressure causes endothelial dysfunction in mouse carotid arteries by increasing local angiotensin signaling. Am J Physiol Heart Circ Physiol 308, H358–H363.
83. Zhou J, Ernsberger P & Douglas JG (1993). A novel angiotensin receptor subtype in rat mesangium. Coupling to adenylyl cyclase. Hypertension 21, 1035–1038.
84. i in myogenic reactivity and arteriolar tone. Am J Physiol Heart Circ Physiol 269, H1590–H1596.
85. 2+ and myosin phosphorylation during myogenic and norepinephrine-induced arteriolar constriction. J Vasc Res 37, 556–567.
86. Zou Y, Akazawa H, Qin Y, Sano M, Takano H, Minamino T, Makita N, Iwanaga K, Zhu W, Kudoh S, Toko H, Tamura K, Kihara M, Nagai T, Fukamizu A, Umemura S, Iiri T, Fujita T & Komuro I (2004). Mechanical stress activates angiotensin II type 1 receptor without the involvement of angiotensin II. Nat Cell Biol 6, 499–506.